Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization

Bevacizumab is an anti-vascular endothelial growth factor drug that can be used to treat choroidal neovascularization (CNV). Bevacizumab-loaded multivesicular liposomes (Bev-MVLs) have been designed and developed to increase the intravitreal retention time of bevacizumab and reduce the number of inj...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Deliv
Main Authors: Mu, Hongjie, Wang, Yiyun, Chu, Yongchao, Jiang, Ying, Hua, Hongchen, Chu, Liuxiang, Wang, Kaili, Wang, Aiping, Liu, Wanhui, Li, Youxin, Fu, Fenghua, Sun, Kaoxiang
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058521/
https://ncbi.nlm.nih.gov/pubmed/29869520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1474967
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados